Эффективность симвастатина в комплексной терапии острого ишемического инсульта при его назначении в острую фазу болезни

1. Bonita R. Stroke prevention: a global perspective. In: JW.Norris, V.Hachinsky, eds. Stroke Prevention. NY: Oxford University Press; 2001: 259–74.
2. World Health Organization (WHO). The World Health Report. 1999. Geneva. WHO 1999.
3. Heart and stroke statistical update. Dallas. Texas. Am Heart Association 2001.
4. Bonita R. Epidemiology of stroke. Lancet 1992; 339: 342–4.
5. Cooke JP, Tsao PS. Is NO an endogenous antiathero-genic molecule? Arterioscler Thromb 1994; 14: 653–5.
6. Furcрт. ст.ott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989; 3: 2007–18.
7. Hahn AW, Resink TJ, Scott-Burden T et al. Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function. Cell Regulation 1990; 1: 649–59.
8. Lusher TF, Barton M. Biology of the endothelium. Clin Cardiol 1997; 10 (Suppl. 11): 3–10.
9. Vane JR, Anggard EE, Batting RM. Regulatory functions of the vascular endotnelium. New Eng J Med 1990: 323: 27–36.
10. Vanhoutte PM. How to assess endothelial function in human blood vessels J Hypertens 1999; 17 (8): 1047–58.
11. Davies MJ, Thomas АС. Plaque fissuring – the cause of acute myocardial infarction, sudden ischemic death, and creshendo angina. Brit Heart J 1985; 53: 363–73.
12. Falk E, Shah PK, Faster V. Coronary plaque disruption. Circulation 1995; 92: 657–71.
13. Fuster V, Lewis A. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology. Circulation 1994: 90: 2126–46.
14. Hladovec J. Circulating endothelial cells as sign of vessel wall lesions. Рhysiol Bohemoslov 1978; 27: 140–4.
15. Беркович О.А., Шляхто Е.В. и соавт. Влияние статинов на функциональное состояние эндотелия сосудов у больных ишемической болезнью сердца. РМЖ. 2002; 10 (19): 874–7.
16. Bory M, Sampol J, Yvorra S et al. Detection des cellules endotheliales circulantes: un nouveau test diagniostique de l` angor de repos Arch Mal Coeur Vaiss 1995; 88 (12): 1827–31.
17. Guidelines for management of ischaemic stroke and transient ischaemie attack. ESO. 2008.
18. Amarenco P, Bogousslavsky J, Callahan A, Goldstein L et al High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 335; 549–59.
19. Bianco M, Nombela F, Castellanos M, Rodriguez-Yanez M et al. Statin treatment withdrawal in ischemic stroke: A controlled randomized study. Neurology 2007; 69: 904–10.
20. Amarenco P, Labreuche J, Lavalle' e P, Touboul P-J. Statin in stroke prevention and carotid atherosclerosis: systematic review and meta-analysis. Stroke 2004; 35: 2902–9.
21. Nickole N Henyan et al. Impact of Statins on Risk of Stroke: A Meta-Analysis. The Annals of Pharmacotherapy 2007; 41 (12): 1937–45.
22. Stead LG, Vaidyanathan L, Kumar G et al. Statins in ischemic stroke: just low-density lipoprotein lowering or more? J Stroke Cerebrovasc Dis 2009; 18: 124–7.
23. Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 2006; 37: 1923–32.
24. Switzer JA, Hess DC. Statin therapy for coronary heart disease and its effect on stroke. Curr Atheroscler Rep 2006; 8: 337–42.
25. Underhill HR, Yuan C, Zhao XQ et al. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. Am Heart J 2008; 155 (584): e581–8.
26. Liao JK. Clinical implications for statin pleiotropy. Curr Opin Lipidol 2005; 16: 624–9.
27. Yrjanheikki J, Koistinaho J, Kettunen M. Long-term protective effect of atorvastatin in permanent focal cerebral ischemia. Brain Res 2005; 1052: 174–9.
28. Kumar S, Savitz S, Schlaug G et al. Antiplatelets, ACE inhibitors, and statins combination reduces stroke severity and tissue at risk. Neurology 2006; 66: 1153–8.

В.В.Якусевич1, А.Ю.Малыгин2, А.С.Петроченко1, С.В.Лыченко1

1 Ярославская государственная медицинская академия;
2 Городская клиническая больница № 8, Ярославль